Navigation Links
Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Date:8/14/2009

ogress (15,954,182) (9,722,463) Proceeds from sales of properties 17,039 61,152 Purchase of equipment and automobiles (921,388) (360,192) Net cash used in investing activities (20,441,748) (9,542,428) CASH FLOWS FROM FINANCING ACTIVITIES: Loan from (repayment to) related parties (3,945,510) 7,400,000 Payments on long term debt, related party -- (1,065,000) Proceeds for joint venture investor in Dongfeng -- 2,828 Payments to minority interest shareholder -- (5,070,091) Increase in paid in capital 163,331 -- Net cash provided by (used in) financing activities (3,782,179) 1,267,737 EFFECT OF EXCHANGE RATE CHANGES ON CASH 64,084 3,053,932 DECREASE IN CASH (10,513,981) (6,340,515) CASH, beginning of period 44,854,511 54,081,848 CASH, end of period $34,340,530 $47,741,333 Supplemental disclosures of cash flow information Cash paid during the period for: Interest $105,817 $132,662 Income taxes $667,347 $1,822,619 TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES REVENUE BY REGION Three months ended June 30, 2009 2008 Change China $9,669,603 $8,509,932 13.6% International $10,881,433 $11,144,515 -2.4% Total
'/>"/>
SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Tiens Biotech Group (USA) Reports First Quarter Results
2. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
3. eFuture Signs Contract to Provide Tiens Group with Retail Business Management System
4. Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results
5. Biotech Hot in July Driven by Positive Drug Data and Acquisitions
6. Cardinal Health Completes Biotech Acquisition
7. Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results
8. PROLOR Biotech Acquires License Option from Yeda for Development of Long-Acting Anti-Obesity Drug
9. Oncolytics Biotech Inc. Successfully Completes 100-Litre cGMP Production of REOLYSIN(R)
10. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
11. Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015  Transwestern | RBJ today announces ... of office space for Shire a leading biopharmaceutical company, at ... Transwestern | RBJ,s Robert Richards , president, and ... lease for the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... 22, 2015 Protocol Networks brings independent ... team of brand-neutral, independent consultants, Protocol Networks has recently ... that over the years, his company has attracted several ... of Plainfield, as well as others. With the success ...
(Date:1/22/2015)... DE (PRWEB) January 22, 2015 Controlled ... Pistoia Alliance, which helps companies check the legal requirements ... to expand to China. , As their international ... are globally adopting software solutions built as a result ...
(Date:1/22/2015)...  Varian Medical Systems (NYSE: VAR ), world leader ... commitment to sustainability with inclusion on a prestigious list of ... healthcare equipment company among the Corporate Knights Global 100 Most ... at Davos, Switzerland . ...
Breaking Biology Technology:Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2Global Compliance Service for Controlled Substances to Expand to China 2Varian Honored Among World's 100 Most Sustainable Corporations 2
...   Hospitals, health systems to benefit,from ... and other,performance management solutions Elsevier ... products,and services, has struck an exclusive partnership with ... learning solutions for process,improvement. Elsevier will market ...
... carbon, has the potential to make consumer electronic devices ... shrinking scale of electronics, also make graphene difficult to ... In September 2010, a UCLA research team ... and were able to fabricate graphene transistors with unparalleled ...
... 2011 Pharmacyclics, Inc. (Nasdaq: PCYC ) ... agreements with various institutional investors and its CEO for ... in a registered direct offering at $8.85 per share, ... of the offering, before deducting expenses, are expected to ...
Cached Biology Technology:Elsevier Strikes Exclusive eLearning Partnership with The Quality Group 2Elsevier Strikes Exclusive eLearning Partnership with The Quality Group 3Elsevier Strikes Exclusive eLearning Partnership with The Quality Group 4UCLA team reports scalable fabrication of self-aligned graphene transistors, circuits 2Pharmacyclics Announces Results of Registered Direct Offering 2Pharmacyclics Announces Results of Registered Direct Offering 3
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ...
(Date:12/17/2014)... 16, 2014 Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ... Chemical Sensor Market 2015-2019" report to their offering. ... One major trend upcoming in this market is the ... sensors help in recording of patient data for quick ...
(Date:12/11/2014)... SALEM, N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... new bacterium in an immune-compromised patient, according to a ... belongs to the family Acetobacteraceae and includes bacteria common ... industry, such as vinegar-making. "This is the first ... of the Acetobacteraceae," according to the article. ...
... single atom from the molecular structure of vancomycin aglycon, ... cell wall synthesis, significantly increasing the drug's spectrum of ... common strains of enterococci have become resistant to vancomycin ... This re-engineering effort could help make the drug more ...
... flu is bad enough for healthy people, but the ... weakened immune systems, such as patients on chemotherapy. A ... of Philadelphia will support research to determine how adults ... vulnerable to influenza, and will seek better ways to ...
Cached Biology News:Soil-bound prions that cause CWD remain infectious 2Scientists re-engineer a well-known antibiotic to counter drug resistance 2How can we protect patients with weakened immune systems from influenza? 2How can we protect patients with weakened immune systems from influenza? 3
... provides a genome-wide microRNA (miRNA) expression profiling ... design, which enable highly sensitive and specific ... standard arrays for mature miRNA of all ... the Sanger miRBase database (Release 8.2). Our ...
... Microarrays designed for immunological studies, vaccine ... the flexible and powerful Paraflo microfluidic ... available as part of our comprehensive ... Custom Probe Content Probe content ...
... Custom peptide microarrays designed for ... serum samples and built on the ... platform. Thousands of customer specified sequences ... Sciences can provide assistance with custom ...
... the first time, you can identify and ... efficiently without interferences. The Agilent Multiple Affinity ... multiple high-abundant proteins from human serum, plasma, ... one device. With this revolutionary system, you ...
Biology Products: